BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 30818163)

  • 1. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
    Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
    Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
    Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
    Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic ductal adenocarcinoma: prevalence and diagnostic value of dark choledochal ring sign on T2-weighted MRI.
    Cha DI; Kim YK; Choi SY; Lim SH; Choi D; Lee WJ
    Clin Radiol; 2014 Apr; 69(4):416-23. PubMed ID: 24457015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
    Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
    Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
    Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
    Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
    Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative detection of small pancreatic carcinoma: value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level.
    Park MJ; Kim YK; Choi SY; Rhim H; Lee WJ; Choi D
    Radiology; 2014 Nov; 273(2):433-43. PubMed ID: 24991989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
    Jia H; Li J; Huang W; Lin G
    BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of noncontrast MRI in differentiation between gallbladder carcinoma and benign conditions manifesting as focal mild wall thickening.
    Cha SY; Kim YK; Min JH; Lee J; Cha DI; Lee SJ
    Clin Imaging; 2019; 54():63-70. PubMed ID: 30551027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-stop-shop preoperative evaluation for living liver donors with gadoxetic acid disodium-enhanced magnetic resonance imaging: efficiency and additional benefit.
    Xie S; Liu C; Yu Z; Ren T; Hou J; Chen L; Huang L; Cheng Y; Ji Q; Yin J; Zhang L; Shen W
    Clin Transplant; 2015 Dec; 29(12):1164-72. PubMed ID: 26448564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding Delayed Phase Images to Dual-Phase Contrast-Enhanced CT Increases Sensitivity for Small Pancreatic Ductal Adenocarcinoma.
    Fukukura Y; Kumagae Y; Fujisaki Y; Yamagishi R; Nakamura S; Kamizono J; Nakajo M; Kamimura K; Nagano H; Takumi K; Yoshiura T
    AJR Am J Roentgenol; 2021 Oct; 217(4):888-897. PubMed ID: 33759561
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
    Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
    Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma.
    Yamaguchi T; Sofue K; Ueshima E; Ueno Y; Tsujita Y; Yabe S; Shirakawa S; Toyama H; Hori M; Fukumoto T; Murakami T
    J Magn Reson Imaging; 2022 Sep; 56(3):725-736. PubMed ID: 35005813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
    Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
    Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
    Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
    Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Multidetector CT and Gadobutrol-Enhanced MR Imaging for Evaluation of Small, Solid Pancreatic Lesions.
    Choi TW; Lee JM; Kim JH; Yu MH; Han JK; Choi BI
    Korean J Radiol; 2016; 17(4):509-21. PubMed ID: 27390542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
    Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
    Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.